<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR341.html">Part 341
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 341.74  Labeling of antitussive drug products.
                            </h3>
                            <p class="depth0"><em>(a)</em> Statement of identity. The labeling of the product contains the  established name of the drug, if any, and identifies the product as a  ``cough suppressant'' or an ``antitussive (cough suppressant).''</p><p class="depth0"><em>(b)</em>, as appropriate. Other truthful and nonmisleading statements,  describing only the indications for use that have been established and  listed in this paragraph, may also be used, as provided in Sec.  330.1(c)(2), subject to the provisions of section 502 of   the act relating to misbranding and the prohibition in section 301(d) of  the act against the introduction or delivery for introduction into  interstate commerce of unapproved new drugs in violation of section  505(a) of the act.</p><p class="depth0"><em>(1)</em> ``Temporarily'' (select one of the following: ``alleviates,''  ``calms,'' ``controls,'' ``decreases,'' ``quiets,'' ``reduces,''  ``relieves,'' or ``suppresses'') ``cough due to'' (select one of the  following: ``minor bronchial irritation'' or ``minor throat and  bronchial irritation'') (select one of the following: ``as may occur  with,'' ``associated with,'' or ``occurring with'') (select one of the  following: ``A cold'' or ``the common cold'') ``or inhaled irritants.''</p><p class="depth0"><em>(2)</em> ``Temporarily'' (select one of the following: ``alleviates,''  ``calms,'' ``controls,'' ``decreases,'' ``quiets,'' ``reduces,''  ``relieves,'' or ``suppresses'') ``cough'' (select one of the following:  ``as may occur with,'' ``associated with,'' or ``occurring with'')  (select one of the following: ``A cold,'' ``the common cold,'' or  ``inhaled irritants'').</p><p class="depth0"><em>(3)</em> In addition to the required information identified in paragraphs  (b) (1) and (2) of this section, the labeling of the product may contain  any (one or more) of the following statements:</p><p class="depth0"><em>(i)</em> ``Cough suppressant which temporarily'' (select one of the  following: ``Alleviates,'' ``controls,'' ``decreases,'' ``reduces,''  ``relieves,'' or ``suppresses'') ``the impulse to cough.''</p><p class="depth0"><em>(ii)</em> ``Temporarily helps you cough less.''</p><p class="depth0"><em>(iii)</em> ``Temporarily helps to'' (select one of the following:  ``Alleviate,'' ``control,'' ``decrease,'' ``reduce,'' ``relieve,'' or  ``suppress'') ``the cough reflex that causes coughing.''</p><p class="depth0"><em>(iv)</em> ``Temporarily'' (select one of the following: ``Alleviates,''  ``controls,'' ``decreases,'' ``reduces,'' ``relieves,'' or  ``suppresses'') ``the intensity of coughing.''</p><p class="depth0"><em>(v)</em> (Select one of the following: ``Alleviates,'' ``Controls,''  ``Decreases,'' ``Reduces,'' ``Relieves,'' or ``Suppresses'') (select one  of the following: ``Cough,'' ``the impulse to cough,'' or ``your  cough'') ``to help you'' (select one of the following: ``Get to sleep,''  ``sleep,'' or ``rest'').</p><p class="depth0"><em>(vi)</em> For products containing chlophedianol hydrochloride, codeine  ingredients, dextromethorphan, or dextromethorphan hydrobromide  identified in Sec. 341.14(a) (1), (2), (3), and (4). ``Calms the cough  control center and relieves coughing.''</p><p class="depth0"><em>(vii)</em> For products containing chlophedianol hydrochloride,  dextromethorphan, dextromethorphan hydrobromide, camphor, or menthol  identified in Sec. 341.14(a) (1), (3), (4) and (b) (1) and (2). (a)  ``Nonnarcotic cough suppressant for the temporary'' (select one of the  following: ``alleviation,'' ``control,'' ``decrease,'' ``reduction,''  ``relief,'' or ``suppression'') ``of cough.''</p><p class="depth0"><em>(b)</em> (Select one of the following: ``Alleviates,'' ``Controls,''  ``Decreases,'' ``Reduces,'' ``Relieves,'' or ``Suppresses'') ``cough  impulses without narcotics.''</p><p class="depth0"><em>(c)</em> Warnings. The labeling of the product contains the following  warnings under the heading ``Warnings'':</p><p class="depth0"><em>(1)</em> For oral and topical antitussives. ``A persistent cough may be a  sign of a serious condition. If cough persists for more than 1 week,  tends to recur, or is accompanied by fever, rash, or persistent  headache, consult a doctor.''</p><p class="depth0"><em>(2)</em> For oral and topical antitussives labeled for adults or for  adults and children under 12 years of age. ``Do not take this product  for persistent or chronic cough such as occurs with smoking, asthma, or  emphysema, or if cough is accompanied by excessive phlegm (mucus) unless  directed by a doctor.''</p><p class="depth0"><em>(3)</em> For oral and topical antitussives labeled only for children  under 12 years of age. ``Do not give this product for persistent or  chronic cough such as occurs with asthma or if cough is accompanied by  excessive phlegm (mucus) unless directed by a doctor.''</p><p class="depth0"><em>(4)</em> Oral antitussives--</p><p class="depth0"><em>(i)</em> For products containing codeine  ingredients identified in Sec. 341.14(a)(2). ``May cause or aggravate  constipation.''</p><p class="depth0"><em>(ii)</em> For products containing codeine ingredients identified in Sec.  341.14(a)(2) when labeled only for adults. ``Do not take this product if  you have a chronic pulmonary disease or shortness of breath unless  directed by a doctor.''</p><p class="depth0"><em>(iii)</em> For products containing codeine ingredients identified in  Sec. 341.14(a)(2) when labeled only for children under 12 years of age.  ``Do not give this product to children who have a chronic pulmonary   disease, shortness of breath, or who are taking other drugs unless  directed by a doctor.''</p><p class="depth0"><em>(iv)</em> For products containing codeine ingredients identified in Sec.  341.14(a)(2) when labeled for use in adults and children under 12 years  of age. ``Adults and children who have a chronic pulmonary disease or  shortness of breath, or children who are taking other drugs, should not  take this product unless directed by a doctor.''</p><p class="depth0"><em>(v)</em> For products containing dextromethorphan or dextromethorphan  hydrobromide as identified in Sec. 341.14 (a)(3) and (a)(4) when  labeled for adults or for adults and children under 12 years of age.  Drug interaction precaution. ``Do not use if you are now taking a  prescription monoamine oxidase inhibitor (MAOI) (certain drugs for  depression, psychiatric, or emotional conditions, or Parkinson's  disease), or for 2 weeks after stopping the MAOI drug. If you do not  know if your prescription drug contains an MAOI, ask a doctor or  pharmacist before taking this product.''</p><p class="depth0"><em>(vi)</em> For products containing dextromethorphan or dextromethorphan  hydrobromide as identified in Sec. 341.14 (a)(3) and (a)(4) when  labeled only for children under 12 years of age. Drug interaction  precaution. ``Do not use in a child who is taking a prescription  monoamine oxidase inhibitor (MAOI) (certain drugs for depression,  psychiatric, or emotional conditions, or Parkinson's disease), or for 2  weeks after stopping the MAOI drug. If you do not know if your child's  prescription drug contains an MAOI, ask a doctor or pharmacist before  giving this product.''</p><p class="depth0"><em>(vii)</em> For products containing diphenhydramine citrate or  diphenhydramine hydrochloride identified in Sec. 341.14 (a)(5) and  (a)(6). ``May cause excitability especially in children.''</p><p class="depth0"><em>(viii)</em> For products containing diphenhydramine citrate or  diphenhydramine hydrochloride identified in Sec. 341.14 (a)(5) and  (a)(6) when labeled only for children under 12 years of age--</p><p class="depth0"><em>(A)</em> ``Do  not give this product to children who have a breathing problem such as  chronic bronchitis, or who have glaucoma, without first consulting the  child's doctor.''</p><p class="depth0"><em>(B)</em> ``May cause marked drowsiness. Sedatives and tranquilizers may  increase the drowsiness effect. Do not give this product to children who  are taking sedatives or tranquilizers, without first consulting the  child's doctor.''</p><p class="depth0"><em>(C)</em> ``Do not use [bullet] \1\ with any other product containing  diphenhydramine, even one used on skin''. ---------------------------------------------------------------------------</p><p class="depth0">\1\ See Sec. 201.66(b)(4) of this chapter for definition of bullet  symbol. ---------------------------------------------------------------------------</p><p class="depth0"><em>(ix)</em> For products containing diphenhydramine citrate or  diphenhydramine hydrochloride identified in Sec. 341.14 (a)(5) and  (a)(6) when labeled for use in adults and children under 12 years of  age--</p><p class="depth0"><em>(A)</em> ``Do not take this product, unless directed by a doctor, if you  have a breathing problem such as emphysema or chronic bronchitis, or if  you have glaucoma or difficulty in urination due to enlargement of the  prostate gland.''</p><p class="depth0"><em>(B)</em> ``May cause marked drowsiness; alcohol, sedatives, and  tranquilizers may increase the drowsiness effect. Avoid alcoholic  beverages while taking this product. Do not take this product if you are  taking sedatives or tranquilizers, without first consulting your doctor.  Use caution when driving a motor vehicle or operating machinery.''</p><p class="depth0"><em>(C)</em> ``Do not use [bullet] with any other product containing  diphenhydramine, even one used on skin''.</p><p class="depth0"><em>(5)</em> Topical antitussives--</p><p class="depth0"><em>(i)</em> For products containing camphor or  menthol identified in Sec. 341.14 (b) (1) and (2) in a suitable  ointment vehicle. ``For external use only. Do not take by mouth or place  in nostrils.''</p><p class="depth0"><em>(ii)</em> For products containing camphor or menthol identified in Sec.  341.14(b) (1) and (2) for steam inhalation use. ``For steam inhalation  only. Do not take by mouth.''</p><p class="depth0"><em>(iii)</em> For any product containing camphor or menthol in a suitable  ointment vehicle or for steam inhalation use and meets the definition of  one of the signal words (``extremely flammable,'' ``flammable,''  ``combustible'') as described in 16 CFR 1500.3(b)(10). The labeling  contains the appropriate flammability signal word(s) followed by a colon  and the statement ``Keep away from fire or flame.''</p><p class="depth0"><em>(iv)</em> For any product containing camphor or menthol in a suitable  ointment vehicle and that does not contain a flammability signal word as  described in 16 CFR 1500.3(b)(10). ``When using this product, do not  [bullet] \1\ heat [bullet] microwave [bullet] add to hot water or any  container where heating water. May cause splattering and result in  burns.'' [Information highlighted in bold type.] ---------------------------------------------------------------------------</p><p class="depth0">\1\ For a definition of the term ``bullet,'' see Sec. 201.66(b)(4)  of this chapter. ---------------------------------------------------------------------------</p><p class="depth0"><em>(v)</em> For any product containing camphor or menthol in a suitable  ointment vehicle and that contains a flammability signal word as  described in 16 CFR 1500.3(b)(10). ``When using this product, do not  [bullet] heat [bullet] microwave [bullet] use near an open flame  [bullet] add to hot water or any container where heating water. May  cause splattering and result in burns.'' [Information highlighted in  bold type.]</p><p class="depth0"><em>(vi)</em> For any product containing camphor or menthol for steam  inhalation use. ``When using this product, do not [bullet] heat [bullet]  microwave [bullet] use near an open flame [bullet] add to hot water or  any container where heating water except when adding to cold water only  in a hot steam vaporizer. May cause splattering and result in burns.''  [Information highlighted in bold type.]</p><p class="depth0"><em>(vii)</em> For any product formulated in a volatile vehicle. The labeling  contains the following statement under the heading ``Other  information'': ``Close container tightly and store at room temperature  away from heat.''</p><p class="depth0"><em>(d)</em> Directions. The labeling of the product contains the following  information under the heading ``Directions'':</p><p class="depth0"><em>(1)</em> Oral antitussives--</p><p class="depth0"><em>(i)</em> For products containing chlophedianol  hydrochloride identified in Sec. 341.14(a)(1). Adults and children 12  years of age and over: Oral dosage is 25 milligrams every 6 to 8 hours,  not to exceed 100 milligrams in 24 hours, or as directed by a doctor.  Children 6 to under 12 years of age: Oral dosage is 12.5 milligrams  every 6 to 8 hours, not to exceed 50 milligrams in 24 hours, or as  directed by a doctor. Children under 6 years of age: Consult a doctor.</p><p class="depth0"><em>(ii)</em> For products containing codeine ingredients identified in Sec.  341.14(a)(2). Adults and children 12 years of age and over: Oral dosage  is 10 to 20 milligrams every 4 to 6 hours, not to exceed 120 milligrams  in 24 hours, or as directed by a doctor. Children 6 to under 12 years of  age: Oral dosage is 5 to 10 milligrams every 4 to 6 hours, not to exceed  60 milligrams in 24 hours, or as directed by a doctor. Children under 6  years of age: Consult a doctor. A special measuring device should be  used to give an accurate dose of this product to children under 6 years  of age. Giving a higher dose than recommended by a doctor could result  in serious side effects for your child.</p><p class="depth0"><em>(iii)</em> For products containing dextromethorphan or dextromethorphan  hydrobromide identified in Sec. 341.14(a) (3) and (4). The dosage is  equivalent to dextromethorphan hydrobromide. Adults and children 12  years of age and over: Oral dosage is 10 to 20 milligrams every 4 hours  or 30 milligrams every 6 to 8 hours, not to exceed 120 milligrams in 24  hours, or as directed by a doctor. Children 6 to under 12 years of age:  Oral dosage is 5 to 10 milligrams every 4 hours or 15 milligrams every 6  to 8 hours, not to exceed 60 milligrams in 24 hours, or as directed by a  doctor. Children 2 to under 6 years of age: Oral dosage is 2.5 to 5  milligrams every 4 hours or 7.5 milligrams every 6 to 8 hours, not to  exceed 30 milligrams in 24 hours, or as directed by a doctor. Children  under 2 years of age: Consult a doctor.</p><p class="depth0"><em>(iv)</em> For products containing diphenhydramine citrate identified in  Sec. 341.14(a)(5). Adults and children 12 years of age and over: oral  dosage is 38 milligrams every 4 hours, not to exceed 228 milligrams in  24 hours, or as directed by a doctor. Children 6 to under 12 years of  age: oral dosage is 19 milligrams every 4 hours, not to exceed 114  milligrams in 24 hours, or as directed by a doctor. Children under 6  years of age: consult a doctor.</p><p class="depth0"><em>(v)</em> For products containing diphenhydramine hydrochloride identified  in Sec. 341.14(a)(6). Adults and children 12 years of age and over:  oral dosage is 25 milligrams every 4 hours, not to exceed 150 milligrams  in 24 hours, or as directed by a doctor. Children 6 to under   12 years of age: oral dosage is 12.5 milligrams every 4 hours, not to  exceed 75 milligrams in 24 hours, or as directed by a doctor. Children  under 6 years of age: consult a doctor.</p><p class="depth0"><em>(2)</em> Topical antitussives--</p><p class="depth0"><em>(i)</em> For products containing camphor  identified in Sec. 341.14(b)(1) in a suitable ointment vehicle. The  product contains 4.7 to 5.3 percent camphor. ``[bullet] see important  warnings under `When using this product' [appears as the first statement  under the heading ``Directions'' and is highlighted in bold type]  [bullet] adults and children 2 years and older: [bullet] rub on the  throat and chest in a thick layer [bullet] cover with a warm, dry cloth  if desired [bullet] clothing should be loose about throat and chest to  help vapors reach the nose and mouth [bullet] use up to three times  daily or as directed by a doctor [bullet] children under 2 years of age:  Ask a doctor.</p><p class="depth0"><em>(ii)</em> For products containing menthol identified in Sec.  341.14(b)(2) in a suitable ointment vehicle. The product contains 2.6 to  2.8 percent menthol. ``[bullet] see important warnings under 'When using  this product' '' [appears as the first statement under the heading  ``Directions'' and is highlighted in bold type] [bullet] adults and  children 2 years and older: [bullet] rub on the throat and chest in a  thick layer [bullet] cover with a warm, dry cloth if desired [bullet]  clothing should be loose about throat and chest to help vapors reach the  nose and mouth [bullet] use up to three times daily or as directed by a  doctor [bullet] children under 2 years of age: Ask a doctor.</p><p class="depth0"><em>(iii)</em> For products containing menthol identified in Sec.  341.14(b)(2) in a lozenge. The product contains 5 to 10 milligrams  menthol. Adults and children 2 to under 12 years of age: Allow lozenge  to dissolve slowly in the mouth. May be repeated every hour as needed or  as directed by a doctor. Children under 2 years of age: Consult a  doctor.</p><p class="depth0"><em>(iv)</em> For products containing camphor identified in Sec.  341.14(b)(1) for steam inhalation use. The product contains 6.2 percent  camphor. ``[bullet] see important warnings under `When using this  product' '' [appears as the first statement under the heading  ``Directions'' and is highlighted in bold type] [bullet] adults and  children 2 years and older: (select one of the following, as  appropriate: For products formulated to be added directly to cold water  inside a hot steam vaporizer. [bullet] use 1 tablespoonful of solution  for each quart of water or 1\1/2\ teaspoonsful of solution for each pint  of water [bullet] add solution directly to cold water only in a hot  steam vaporizer [bullet] follow manufacturer's directions for using  vaporizer or For products formulated to be placed in the medication  chamber of a hot steam vaporizer. [bullet] place water in the vaporizer  and follow manufacturer's directions for using vaporizer [bullet] place  solution in the medication chamber only) [bullet] breathe in the  medicated vapors [bullet] use up to three times daily or as directed by  a doctor [bullet] children under 2 years of age: Ask a doctor.</p><p class="depth0"><em>(v)</em> For products containing menthol identified in Sec. 341.14(b)(2)  for steam inhalation use. The product contains 3.2 percent menthol.  ``[bullet] see important warnings under `When using this product'  ''[appears as the first statement under the heading ``Directions'' and  is highlighted in bold type] [bullet] adults and children 2 years and  older: (select one of the following, as appropriate: For products  formulated to be added directly to cold water inside a hot steam  vaporizer. [bullet] use 1 tablespoonful of solution for each quart of  water or 1\1/2\ teaspoonsful of solution for each pint of water [bullet]  add solution directly to cold water only in a hot steam vaporizer  [bullet] follow manufacturer's directions for using vaporizer or For  products formulated to be placed in the medication chamber of a hot  steam vaporizer. [bullet] place water in the vaporizer and follow  manufacturer's directions for using vaporizer [bullet] place solution in  the medication chamber only) [bullet] breathe in the medicated vapors  [bullet] use up to three times daily or as directed by a doctor [bullet]  children under 2 years of age: Ask a doctor.</p><p class="depth0"><em>(e)</em> The word ``physician'' may be substituted for the word  ``doctor'' in any of the labeling statements in this section.</p><p class="depth0"><em>(f)</em> Exemption from the general accidental overdose warning. The  labeling   for antitussive drug products containing the active ingredient  identified in Sec. 341.14(b)(2) marketed in accordance with Sec.  341.74(d)(2)(iii) is exempt from the requirement in Sec. 330.1(g) of  this chapter that the labeling bear the general warning statement ``In  case of accidental overdose, seek professional assistance or contact a  poison control center immediately.'' The labeling must continue to bear  the first part of the general warning in Sec. 330.1(g) of this chapter,  which states, ``Keep this and all drugs out of the reach of children.''  [52 FR 30055, Aug. 12, 1987; 52 FR 35610, Sept. 22, 1987; 53 FR 35809,  Sept. 15, 1988; 55 FR 27808, July 6, 1990; 55 FR 40383, Oct. 3, 1990; 58  FR 54236, Oct. 20, 1993; 59 FR 29174, June 3, 1994; 59 FR 36051, July  15, 1994; 64 FR 13295, Mar. 17, 1999; 65 FR 8, Jan. 3, 2000; 65 FR  46867, Aug. 1, 2000; 67 FR 72559, Dec. 6, 2002]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
